[
  {
    "ts": null,
    "headline": "Charles River Laboratories International Inc. stock outperforms competitors on strong trading day",
    "summary": "Charles River Laboratories International Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=c890126ca035dbf34747c3a74c9a4d60d8db21e16da99342ffcca940e2358dd4",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745342400,
      "headline": "Charles River Laboratories International Inc. stock outperforms competitors on strong trading day",
      "id": 134092879,
      "image": "",
      "related": "CRL",
      "source": "MarketWatch",
      "summary": "Charles River Laboratories International Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=c890126ca035dbf34747c3a74c9a4d60d8db21e16da99342ffcca940e2358dd4"
    }
  },
  {
    "ts": null,
    "headline": "Upslope Capital Management Sold Charles River (CRL) Due to Thesis Break",
    "summary": "Upslope Capital Management, an investment management firm, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here. The First quarter was challenging for the fund. However, the world has transformed in the two weeks since March 31, due to a drastic realignment of international trade rules. As a result, markets […]",
    "url": "https://finnhub.io/api/news?id=b37b93066dd79e30177e16a845c08b576c883e4e9802cdef1e1952248976cc3a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745330518,
      "headline": "Upslope Capital Management Sold Charles River (CRL) Due to Thesis Break",
      "id": 134039726,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "Upslope Capital Management, an investment management firm, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here. The First quarter was challenging for the fund. However, the world has transformed in the two weeks since March 31, due to a drastic realignment of international trade rules. As a result, markets […]",
      "url": "https://finnhub.io/api/news?id=b37b93066dd79e30177e16a845c08b576c883e4e9802cdef1e1952248976cc3a"
    }
  },
  {
    "ts": null,
    "headline": "Charles River Leverages Advanced Technology to Expedite Oncology Drug Discovery and Development",
    "summary": "WILMINGTON, Mass., April 22, 2025--Ahead of AACR 2025, Charles River announces updates to its comprehensive portfolio to support the discovery and development of novel oncology drugs.",
    "url": "https://finnhub.io/api/news?id=a0fe2d951ab244216b01a7e5702313be5632db4fbfa0d3e4178ad33a0bde2429",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745323200,
      "headline": "Charles River Leverages Advanced Technology to Expedite Oncology Drug Discovery and Development",
      "id": 134039727,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "WILMINGTON, Mass., April 22, 2025--Ahead of AACR 2025, Charles River announces updates to its comprehensive portfolio to support the discovery and development of novel oncology drugs.",
      "url": "https://finnhub.io/api/news?id=a0fe2d951ab244216b01a7e5702313be5632db4fbfa0d3e4178ad33a0bde2429"
    }
  }
]